The Sullivan model appears credible, the participants said, in that the mathematical equations did not seem to have been forced into the service of a desired result. Participants felt that this model seems to have been built on conservative, common-sense assumptions that are easily understood. When the user of a model understands that the model [...]
The effect of ADRs on overall treatment costs among SRIs can be substantial. In the model presented during the round-tables, a branded SRI, escitalopram (Lexapro canadian, Forest) incurred the lowest overall expected cost over the course of six months, ahead of another branded SRI, canadian citalopram (Celexa drug, Forest), and a generic SRI, fluoxetine. (Table [...]
This article summarizes the responses provided by participants in two roundtable discussions to a pharmacoeconomic model of the class of serotonin reuptake inhibitors (SRIs).
